Trial Profile
A Prospective Observational Study to Assess the Impact of RoActemra on the Use of Glucocorticoids in Patients With Rheumatoid Arthritis Treated With the Standard of Care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2012 New trial record